Evaluating the efficacy of eicosapentanoic acid on modified Rankin scale and inflammatory biomarkers in patients with ischemic stroke.
Phase 3
Recruiting
- Conditions
- Ischemic stroke.Cerebral infarction
- Registration Number
- IRCT20170608034390N15
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patients older than 18 years
Ischemic stroke
Hospitalized in neurology ward
Exclusion Criteria
Patients that are under treatment with Alteplase
Patients with the history of allergy to fish liver oil and its derivatives.
Patients with platelet level Count < 50,000.
Patients with active bleeding.
Patients with active systemic bleeding disorders.
Pregnancy
Lactation
Patients with severe stroke (NIHSS score >20).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method